| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 423.70B | 362.01B | 400.92B | 328.59B | 130.36B |
| Gross Profit | 111.32B | 88.49B | 76.93B | 66.54B | 34.26B |
| EBITDA | 117.43B | 90.21B | 78.91B | 51.16B | 27.14B |
| Net Income | 72.20B | 50.74B | 44.12B | 30.73B | 15.93B |
Balance Sheet | |||||
| Total Assets | 974.83B | 786.66B | 717.17B | 600.95B | 307.67B |
| Cash, Cash Equivalents and Short-Term Investments | 392.51B | 317.79B | 264.31B | 193.02B | 90.44B |
| Total Debt | 97.42B | 113.52B | 118.15B | 93.27B | 50.49B |
| Total Liabilities | 603.80B | 513.20B | 497.28B | 424.04B | 215.04B |
| Stockholders Equity | 337.11B | 246.93B | 197.71B | 164.48B | 84.51B |
Cash Flow | |||||
| Free Cash Flow | 90.88B | 68.89B | 60.95B | 14.02B | -620.69M |
| Operating Cash Flow | 133.22B | 100.64B | 94.60B | 63.26B | 42.42B |
| Investing Cash Flow | -94.48B | -49.65B | -27.99B | -64.11B | -52.33B |
| Financing Cash Flow | -6.31B | -16.79B | 11.80B | 81.87B | 22.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$2.05T | 28.13 | 22.82% | 0.21% | 5.28% | ― | |
73 Outperform | HK$94.22B | 9.94 | 7.51% | ― | 11.05% | 81.01% | |
72 Outperform | HK$61.07B | 7.92 | 11.78% | 5.34% | 3.68% | 7.86% | |
65 Neutral | HK$12.31B | 17.06 | 4.42% | 2.52% | ― | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | HK$58.49B | 27.82 | 2.28% | ― | 16.36% | 102.93% | |
53 Neutral | HK$11.69B | -63.97 | -43.42% | ― | -33.94% | -119.13% |